Capstone Therapeutics Corporation held its annual meeting of stockholders on November 18, 2025. At the meeting, two nominees for Class I director, Fredric J. Feldman, Ph.D. and Elwood D. Howse, Jr., were elected. Stockholders approved the ratification of GBQ Partners LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025. The proposal to change the state of incorporation from Delaware to Nevada was approved. Stockholders also approved the adoption of the Capstone Holding Corp. 2025 Stock Incentive Plan.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capstone Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-114137), on November 24, 2025, and is solely responsible for the information contained therein.